Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, $0.00001 par value per share
-
Shares outstanding
-
189,947,836
-
Number of holders
-
84
-
Total 13F shares, excl. options
-
37,428,616
-
Shares change
-
+447,622
-
Total reported value, excl. options
-
$183,549,240
-
Value change
-
+$443,975
-
Put/Call ratio
-
69%
-
Number of buys
-
37
-
Number of sells
-
-39
-
Price
-
$4.90
Significant Holders of Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) as of Q3 2021
102 filings reported holding WVE - Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share as of Q3 2021.
Wave Life Sciences Ltd. - Common Stock, $0.00001 par value per share (WVE) has 84 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37,428,616 shares
of 189,947,836 outstanding shares and own 19.7% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (7,775,207 shares), PRIMECAP MANAGEMENT CO/CA/ (4,568,975 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3,214,340 shares), MAVERICK CAPITAL LTD (3,193,389 shares), BlackRock Inc. (2,837,787 shares), Bellevue Group AG (2,602,858 shares), D. E. Shaw & Co., Inc. (1,101,650 shares), MILLENNIUM MANAGEMENT LLC (1,081,864 shares), JPMORGAN CHASE & CO (1,015,147 shares), and Artal Group S.A. (1,000,000 shares).
This table shows the top 84 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.